Latest Insider Transactions at Insmed Inc (INSM)
This section provides a real-time view of insider transactions for Insmed Inc (INSM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INSMED Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INSMED Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 05
2023
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
720
-1.42%
|
$13,680
$19.72 P/Share
|
|
Jan 05
2023
|
John Drayton Wise Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,598
+8.87%
|
-
|
|
Jan 05
2023
|
John Drayton Wise Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,160
-1.62%
|
$22,040
$19.74 P/Share
|
|
Jan 05
2023
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,144
+6.96%
|
-
|
|
Jan 05
2023
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,374
-2.07%
|
$26,106
$19.73 P/Share
|
|
Jan 05
2023
|
William Lewis Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
22,353
+7.59%
|
-
|
|
Jan 05
2023
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
7,008
-2.73%
|
$133,152
$19.8 P/Share
|
|
Jan 05
2023
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,332
+7.82%
|
-
|
|
Jan 05
2023
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,448
-2.08%
|
$27,512
$19.73 P/Share
|
|
Jan 05
2023
|
Sara Bonstein Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,297
+9.14%
|
-
|
|
Jan 05
2023
|
Roger Adsett Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,598
+5.19%
|
-
|
|
Jan 05
2023
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,044
-2.27%
|
$57,836
$19.75 P/Share
|
|
Nov 22
2022
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
11,855
-8.12%
|
$213,390
$18.8 P/Share
|
|
Nov 22
2022
|
John Drayton Wise Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,154
-9.08%
|
$128,772
$18.84 P/Share
|
|
Nov 01
2022
|
Melvin Md Sharoky Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+38.61%
|
$170,000
$17.7 P/Share
|
|
Oct 31
2022
|
Leo Lee Director |
BUY
Open market or private purchase
|
Direct |
45,000
+31.41%
|
$765,000
$17.69 P/Share
|
|
Oct 31
2022
|
Melvin Md Sharoky Director |
BUY
Open market or private purchase
|
Direct |
20,000
+6.64%
|
$340,000
$17.53 P/Share
|
|
Aug 10
2022
|
John Drayton Wise Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
258
-0.33%
|
$6,966
$27.79 P/Share
|
|
Aug 08
2022
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Indirect |
216,800
-100.0%
|
$6,070,400
$28.08 P/Share
|
|
Aug 08
2022
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
216,800
+50.0%
|
$650,400
$3.98 P/Share
|
|
Jul 12
2022
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
941
-1.83%
|
$21,643
$23.4 P/Share
|
|
Jul 07
2022
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
96,614
-27.34%
|
$2,222,122
$23.0 P/Share
|
|
Jul 07
2022
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
96,614
+21.47%
|
$1,545,824
$16.16 P/Share
|
|
May 23
2022
|
John Drayton Wise Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,236
+25.14%
|
-
|
|
May 17
2022
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
5,996
-2.29%
|
$119,920
$20.18 P/Share
|
|
May 17
2022
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,055
-2.04%
|
$21,100
$20.37 P/Share
|
|
May 17
2022
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,670
-2.37%
|
$33,400
$20.27 P/Share
|
|
May 17
2022
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,022
-1.37%
|
$40,440
$20.34 P/Share
|
|
May 16
2022
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
3,398
-1.28%
|
$61,164
$18.35 P/Share
|
|
May 16
2022
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
433
-0.83%
|
$7,794
$18.48 P/Share
|
|
May 16
2022
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,114
-1.56%
|
$20,052
$18.41 P/Share
|
|
May 16
2022
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,574
-2.31%
|
$28,332
$18.51 P/Share
|
|
May 16
2022
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,433
-2.55%
|
$25,794
$18.51 P/Share
|
|
May 16
2022
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,394
-0.93%
|
$25,092
$18.45 P/Share
|
|
May 11
2022
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,968
+24.42%
|
-
|
|
May 11
2022
|
Sara Bonstein Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,137
+26.41%
|
-
|
|
May 11
2022
|
Roger Adsett Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,460
+15.53%
|
-
|
|
May 11
2022
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,645
+16.98%
|
-
|
|
May 11
2022
|
Michael Alexander Smith Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,645
+21.95%
|
-
|
|
May 11
2022
|
William Lewis Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
47,598
+15.22%
|
-
|
|
May 11
2022
|
Melvin Md Sharoky Director |
BUY
Open market or private purchase
|
Direct |
20,000
+7.08%
|
$340,000
$17.2 P/Share
|
|
May 11
2022
|
Melvin Md Sharoky Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,645
+5.69%
|
-
|
|
May 11
2022
|
Carol Schafer Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,645
+31.46%
|
-
|
|
May 11
2022
|
David W J Mcgirr Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,645
+16.79%
|
-
|
|
May 11
2022
|
Leo Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,645
+21.57%
|
-
|
|
May 11
2022
|
Clarissa Desjardins Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,645
+29.15%
|
-
|
|
May 11
2022
|
David R Brennan Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,645
+13.29%
|
-
|
|
May 11
2022
|
Elizabeth M Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,645
+25.71%
|
-
|
|
May 11
2022
|
Alfred Altomari Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,645
+25.34%
|
-
|
|
Mar 23
2022
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
96,614
-11.92%
|
$2,222,122
$23.31 P/Share
|